RBOT vs. LAKE, LUCD, PROF, INO, RCEL, ZJYL, SPAI, OBIO, NSPR, and FONR
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Lakeland Industries (LAKE), Lucid Diagnostics (LUCD), Profound Medical (PROF), Inovio Pharmaceuticals (INO), Avita Medical (RCEL), Jin Medical International (ZJYL), Safe Pro Group (SPAI), Orchestra BioMed (OBIO), InspireMD (NSPR), and Fonar (FONR). These companies are all part of the "medical equipment" industry.
Vicarious Surgical vs. Its Competitors
Vicarious Surgical (NYSE:RBOT) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.
Vicarious Surgical has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.
Vicarious Surgical has a net margin of 0.00% compared to Lakeland Industries' net margin of -13.31%. Lakeland Industries' return on equity of -6.88% beat Vicarious Surgical's return on equity.
Vicarious Surgical currently has a consensus target price of $7.00, indicating a potential upside of 22.91%. Lakeland Industries has a consensus target price of $26.00, indicating a potential upside of 73.33%. Given Lakeland Industries' stronger consensus rating and higher probable upside, analysts clearly believe Lakeland Industries is more favorable than Vicarious Surgical.
In the previous week, Lakeland Industries had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 4 mentions for Lakeland Industries and 2 mentions for Vicarious Surgical. Vicarious Surgical's average media sentiment score of 0.78 beat Lakeland Industries' score of 0.51 indicating that Vicarious Surgical is being referred to more favorably in the media.
Lakeland Industries has higher revenue and earnings than Vicarious Surgical. Lakeland Industries is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are owned by institutional investors. 12.0% of Vicarious Surgical shares are owned by company insiders. Comparatively, 1.9% of Lakeland Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Lakeland Industries beats Vicarious Surgical on 10 of the 15 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vicarious Surgical Competitors List
Related Companies and Tools
This page (NYSE:RBOT) was last updated on 9/4/2025 by MarketBeat.com Staff
Free RBOT Stock Alerts